rs2070959

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025). O4_SupportingB1_StrongB3_Supporting

The NM_001072.4(UGT1A6):c.541A>G (p.Thr181Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene UGT1A6 is a cancer driver gene (CancerMine: 1 driver citations). The variant allele was found at a cumulative frequency of 0.319 (AC=515,475) in the gnomAD database across 1,613,956 control chromosomes, including 84,631 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.397. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★). The variant has been observed in cBioPortal in 6 samples across 5 studies and 5 cancer types; somatic enrichment level: SUPPORTING (Observed repeatedly in cBioPortal somatic datasets.). This exact variant is curated in the UniProt human variants database as Uncertain Significance.

Frequency

Genomes: 𝑓 0.30 ( 7183 hom., cov: 32)
Exomes 𝑓: 0.32 ( 77448 hom. )

Consequence

UGT1A6
NM_001072.4 missense

Scores

17

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.39

Publications

179 publications found
Variant links:
Genes affected
UGT1A6 (HGNC:12538): (UDP glucuronosyltransferase family 1 member A6) This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene is active on phenolic and planar compounds. Alternative splicing in the unique 5' end of this gene results in two transcript variants. [provided by RefSeq, Jul 2008]
UGT1A10 (HGNC:12531): (UDP glucuronosyltransferase family 1 member A10) This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has glucuronidase activity on mycophenolic acid, coumarins, and quinolines. [provided by RefSeq, Jul 2008]
UGT1A8 (HGNC:12540): (UDP glucuronosyltransferase family 1 member A8) This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has glucuronidase activity with many substrates including coumarins, phenols, anthraquinones, flavones, and some opioids. [provided by RefSeq, Jul 2008]
UGT1A7 (HGNC:12539): (UDP glucuronosyltransferase family 1 member A7) This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has moderate glucuronidase activity with phenols. [provided by RefSeq, Jul 2008]
UGT1A9 (HGNC:12541): (UDP glucuronosyltransferase family 1 member A9) This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene is active on phenols. [provided by RefSeq, Jul 2008]
UGT1A (HGNC:12529): (UDP glucuronosyltransferase family 1 member A complex locus) This RefSeq represents a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001072.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -4 points.

O4Enriched in somatic variant database
Enriched in cBioPortal (pre-computed score ≥ 1.0) — Supporting (O4); cBioPortal: samples=6 | studies=5 | cancer types=5 | level=SUPPORTING | points=1.0 | reason: Observed repeatedly in cBioPortal somatic datasets.
B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.397 — exceeds 1% threshold (B1 applied)
B3Computational evidence does not support deleterious effect
Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001072.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

UGT1A6 NM_001072.4
MANE Select
HGVSc / HGVSpc.541A>Gp.Thr181Ala
Exon rankExon 1 of 5
missense
Prot: NP_001063.2
UGT1A10 NM_019075.4
MANE Select
HGVSc / HGVSpc.855+56168A>G
Exon rankIntron 1 of 4
intron
Prot: NP_061948.1UniProt: Q5DT02Q9HAW8-1
UGT1A8 NM_019076.5
MANE Select
HGVSc / HGVSpc.856-73489A>G
Exon rankIntron 1 of 4
intron
Prot: NP_061949.3

Ensembl Transcripts

UGT1A6 ENST00000305139.11
TSL:1MANE Select
HGVSc / HGVSpc.541A>Gp.Thr181Ala
Exon rankExon 1 of 5
missense
Prot: ENSP00000303174.6UniProt: P19224-1
UGT1A10 ENST00000344644.10
TSL:1MANE Select
HGVSc / HGVSpc.855+56168A>G
Exon rankIntron 1 of 4
intron
Prot: ENSP00000343838.5UniProt: Q9HAW8-1
UGT1A9 ENST00000354728.5
TSL:1MANE Select
HGVSc / HGVSpc.855+20756A>G
Exon rankIntron 1 of 4
intron
Prot: ENSP00000346768.4UniProt: O60656-1

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.300
AC:45649
Hom:7190
AN:151972
Cov:32
GnomAD2 exomes
AF: 0.312
AC:78275
AN:251278
GnomAD4 exome
AF: 0.321
AC:469827
Hom:77448
AN:1461866
Cov:93
GnomAD4 genome
AF: 0.300
AC:45648
Hom:7183
AN:152090
Cov:32
TOPMed (Bravo)
AF: 0.279
AC:73783
Hom:10705
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.314
AC:240287
Hom:38653
AN:765074
Local & regional cohorts 11 sources
ABraOM SABE-WGS-1171
AF: 0.292
AC:685
Hom:108
AN:2342
ChinaMAP Phase 1
AF: 0.222
Denmark Genome
AF: 0.323
AC:97
AN:300
ESP6500 (Exome Variant Server)
AF: 0.305
AC:3962
AN:13006
GenomeAsia100K
AF: 0.277
AC:969
AN:3478
Korea4K (4,157 Koreans)
AF: 0.235
AC:1698
AN:7232
Qatari Genome
AF: 0.327
AC:658
AN:2010
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.245
AC:30128
Hom:3719
AN:122748
Turkish Variome
AF: 0.375
AC:2522
Hom:487
AN:6722
UK10K
AF: 0.319
AC:2412
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.210
AC:1880
Hom:202
AN:8960
Showing 17 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.313 *347511098 0.315 *555217608
BipEx
(Bipolar disorder (including schizoaffective))
0.322 916128420 0.316 910428844
Epi25
(Epilepsy)
0.320 1342741958 0.307 2055166888
SCHEMA
(Schizophrenia)
0.308 42712138656 0.315 70273222822
Showing 4 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational Scores

AlphaGenome AVI
Benign7.8
AlphaMissense
Benign0.067
BayesDel_addAF
Benign-0.80T
BayesDel_noAF
Benign-0.78
CADD
Benign0.088
DANN
Benign0.44
DEOGEN2
Benign0.0052T
Eigen
Benign-1.9
Eigen_PC
Benign-1.9
FATHMM_MKL
Benign0.044N
FuncVEP CTI
Benign0.0026
GPN-Star LLR
N/A3.0
GPN-Star score
N/A-0.76
LIST_S2
Benign0.16T
MetaRNN
Benign0.00058T
MetaSVM
Benign-1.0T
Mutation Taster
N/A99/1polymorphism (auto)
MutationAssessor
Benign0.085N
PhyloP100
Benign-1.4
popEVE
Benign-2.7
PromoterAI
N/A-0.022Neutral
PROVEAN
Benign0.18N
REVEL
Benign0.054
Sift
Benign0.73T
Sift4G
Benign0.77T
Varity_R
N/A0.022
VESM-3B
Benign-3.6
Showing 27 of 27 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

dbSNP: rs2070959;
hg19: chr2-234602191;
COSMIC: COSV59383870;
COSMIC: COSV59383870;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.